# Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

> **NCT02093689** · PHASE3 · TERMINATED · sponsor: **Omeros Corporation** · enrollment: 18 (actual)

## Conditions studied

- Intraocular Lens Replacement
- Intraoperative Floppy Iris Syndrome

## Interventions

- **DRUG:** Part 1 OMS302
- **DRUG:** Part 2 OMS302
- **DRUG:** Part 2 Placebo

## Key facts

- **NCT ID:** NCT02093689
- **Lead sponsor:** Omeros Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Pupil measurement methodology determined not appropriate in this population.
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093689, "Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02093689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*